Refine your search

Content type
Firm name

1,237 results found


Edgeworth Economics | USA | 24 Jul 2020

Lamictal and the Myth of “Generic” “Pay-for-Delay” Cases

On April 22, 2020, the US Court of Appeals for the Third Circuit overturned a district court decision certifying a class of direct purchaser…

Grau & Angulo | European Union, Spain | 1 Jun 2020

Appeal court confirms revocation of Spanish SPC for Truvada

The Barcelona Court of Appeal recently issued a judgment confirming the invalidity of Gilead's supplementary protection certificate (SPC) for the…

Grau & Angulo | European Union, Spain | 20 Jan 2020

Barcelona Court of Appeal confirms refusal of preliminary injunctions against fulvestrant generics

The Barcelona Court of Appeal recently issued two decisions confirming the refusal of the preliminary injunctions that AstraZeneca had requested to…

Loeb & Loeb LLP | USA | 9 Jan 2020

Teva Sales and Marketing Inc. Settlement Agreement

Teva Sales and Marketing Inc, (a subsidiary of Teva Pharmaceuticals) agreed Dec. 28, 2019, to pay $54 million to resolve claims brought by two…

S Horowitz & Co | Israel | 22 Jul 2019

Not worth its salt: Merck's patent application covering JANUVIA® does not survive Teva's opposition

In a decision rendered earlier this month, the Deputy Commissioner of Patents, Jacqueline Bracha, allowed an opposition filed by Teva…

Dilworth IP | USA | 7 May 2019

Pain Treatment, Kidney Failure, and §101

In Endo Pharmaceuticals Inc. v. Teva the Federal Circuit has further clarified the patent eligibility of treatment methods which include natural…

Harness, Dickey & Pierce, PLC | USA | 30 Apr 2019

Prior User Defense Protects Trade Secret Owners Whose Secret is Patented by Another

The inventor of new technology has two choices for protection: patents or trade secrets. They are generally mutually exclusive, because the…

DLA Piper | USA | 11 Apr 2019

Supreme Court Corner Q1 2019

In celebration of the 10th anniversary of IPT News, we note that 10 years ago, in the first quarter of 2009, Bernard L. Bilski filed his petition in…

Bird & Bird LLP | United Kingdom | 27 Mar 2019

Supreme Court holds Dosage Regime Patent Obvious

Today in Actavis v ICOS the Supreme Court unanimously ruled that the ICOS patent for a Tadalafil dosing regime was invalid. Lord Hodge gave the only…

Dilworth IP | USA | 12 Mar 2019

Use Your Calendar & Confidentiality to Protect the Next Big Idea

In January, the Supreme Court issued a ruling on how the commercial life of a new product can become fatal to the possibility of obtaining a patent…
Previous page 1 2 3 ...